Rhythm Corp (RYTM): Pangali rega marang bathi tumrap wutah
The preparation of CMO partners' capacities to expand peptide production triggered a rally captured by the average PEG value shown on this GURU.Markets chart. 0.00 characterizes this valuation parameter. High margins from global orphan drug sales ensure scalability, yet geopolitical instability and raw material supply disruptions create risks for Rhythm Pharmaceuticals (RYTM) clinical trials.
Rincian analitis perusahaan Rhythm Pharmaceuticals (RYTM)
- rega saham lan konsensus proyeksi valuasi:
- data kapitalisasi bursa:
- indikator nilai buku ekuitas:
- statistik kawajiban utang lan likuiditas:
Total Utang marang Modal Rhythm Pharmaceuticals|RYTM - Utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas rhythmtx.com|RYTM - Utang perusahaan|Utang-utang marang nilai buku Rhythm Pharmaceuticals Inc|RYTM - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Rhythm Pharmaceuticals|Koefisien jangkoan perantara rhythmtx.com
- data bathi lan kelipatan valuasi:
RYTM - Bathi resik perusahaan|Prakiraan bathi perusahaan Rhythm Pharmaceuticals|RYTM - Rasio rega marang bathi|Prakiraan rega marang bathi Rhythm Corp|RYTM - Rasio rega marang bathi tumrap wutah|Nilai bisnis marang bathi operasional sadurunge panyusutan Rhythm Pharmaceuticals Inc|RYTM - Bathi operasional EBITDA|Bathi saben saham sajroning taun lumaku Rhythm Pharmaceuticals|RYTM - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham ing petungan tahunan sajrone rolas wulan pungkasan rhythmtx.com|RYTM - Wutah bathi resik saben saham ing taun iki|Proyeksi tambahing bathi saben saham ing taun ngarep Rhythm Pharmaceuticals
Analisis fundamental perusahaan:RYTM - Rhythm Pharma
Investors use this filter to identify undervalued assets by dividing the P/E ratio by earnings growth rates. For Rhythm Pharmaceuticals (RYTM), which has monopolized the rare obesity therapy niche, the current PEG ratio helps determine whether the market valuation aligns with the uniqueness of its sole-source ecosystem, eliminating the risk of purchasing a deteriorating business disguised as a cheap asset.
Pesaing Rhythm Pharmaceuticals
ASND (Ascendis Pharma AS) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Madrigal Pharma MDGL|CORT - Pangali rega marang bathi tumrap wutah|Akero Therapeutics - Pangali PEG|Rega marang bathi kanthi panyesuaian wutah metsera.com|MLTX (MoonLake) - Pangali rega marang bathi tumrap wutah|CRNX: Rasio nilai perusahaan marang wutah bathi|NAMS (NewAmsterdam Pharma N.V.) - Pangali PEG|Pangali PEG Soleno Therapeutics Corp|Pangali PEG FOLD|Rasio rega marang bathi tumrap wutah ETNB (89bio.com)|Rasio rega marang bathi tumrap wutah Agios Pharmaceuticals, Inc. AGIO|Structure Therapeutics Inc (GPCR) - Rega marang bathi kanthi panyesuaian wutah|MDXG - Rasio rega marang bathi tumrap wutah|RZLT: Rasio rega marang bathi tumrap wutah|LXRX: Pangali PEG|MBX - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Altimmune|Aardvark Therapeutics Inc. (AARD) - Kapitalisasi marang bathi resik kanthi nimbang wutah|Rasio rega marang bathi tumrap wutah Sagimet (SGMT)|Pangali rega marang bathi tumrap wutah BioAge Labs, Inc BIOA|Rasio rega marang bathi tumrap wutah Biomea Fusion, Inc. BMEA|Koefisien bali modal nimbang wutah QNCX|Fractyl Health - Pangali PEG|Koefisien bali modal nimbang wutah VTVT (vTv Therapeutics Inc.)|ATPC (agapeatpgroup.com) - Pangali rega marang bathi tumrap wutah|Rega marang bathi kanthi panyesuaian wutah Pluri (PLUR)|Pangali rega marang bathi tumrap wutah SYBX|LPCN (lipocine.com) - Rasio nilai perusahaan marang wutah bathi|Pangali PEG MTNB|SPRB (Spruce Biosciences Inc.) - Koefisien bali modal nimbang wutah|Rasio rega marang bathi tumrap wutah Galecto Corp GLTO|CTCX - Pangali rega marang bathi tumrap wutah|LUMO: Pangali rega marang bathi tumrap wutah|Koefisien bali modal nimbang wutah ONVO (organovo.com)|Radius Recycling (RDUS) - Rasio rega marang bathi tumrap wutah
